Clinical Trial Update: Study to Assess the Activity of Nexrutine® in Prostate Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 study assessing Nexrutine activity in prostate cancer was terminated; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Nexrutine

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2015-06-11